Is there more upside left in specialty chemical stocks?
The sector has been on a tear, especially due to the supply disruption in China
September 08, 2020
This is what the government needs to do to maximize the value of its PSU holdings
Many good PSUs are undervalued because investors are wary about the government's ill-timed selling
Chaitanya Dalmia - September 07, 2020
Crompton Greaves Consumer Electricals has been doing well but there is a tightrope walk ahead
The electricals company has triumphed over its troubled past and now it needs to secure its future
Debangana Ghosh - August 11, 2020
Why EMs are more immune to COVID-19 disruption than DMs
GMO’s EM equity team makes a case for MSCI EM Index’s resilience and speedy recovery
July 30, 2020
Its IPO was overhyped but is it time to relook at SBI Cards?
Listing amidst a pandemic hurt its market cap, but analysts feel the SBI subsidiary could bounce back in FY22
Anishaa Kumar - July 02, 2020
Will we see further earnings downgrade post Q1FY21 results?
As the lockdown continues in several parts of the country, growth is barely picking up
July 16, 2020
Why Ashish Kacholia, Mukul Agrawal and Kedaara Capital are hot on Religare Enterprises
Despite its troubled past, its healthcare insurance business may turn out to be a dark horse
Anishaa Kumar - July 16, 2020
Clean stock market data. The question is, who pays for it?
Tijori Finance offers a float for those fearful of drowning in stock market data, but its business model remains unclear
Rishabh Bhatnagar - July 11, 2020
Is there more upside in store for pharma stocks?
Over the past year, the Nifty Pharma Index has gained 23% while the Nifty has declined by 11%
June 30, 2020
Asset diversification
Veteran fund manager and CIO of HDFC AMC sells one-third of his stake in the company worth Rs.747 million
Shailaja Mohapatra - July 03, 2020
